Journal
NATURAL PRODUCT RESEARCH
Volume 26, Issue 24, Pages 2363-2367Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14786419.2012.662648
Keywords
diabetes mellitus; Eclipta alba; alpha-glucosidase; aldose reductase
Categories
Funding
- CSIR, New Delhi [NWP-0032]
- UGC, New Delhi
- Senior Research Fellowship of CSIR, New Delhi
Ask authors/readers for more resources
The antidiabetic effect of the ethanolic extract of Eclipta alba (EEA) on hyperglycaemia and diabetic nephropathy was investigated in streptozotocin-induced diabetic rats. Single-dose treatment of EEA to streptozotocin-induced diabetic rats lowered the blood glucose level by 17.6% (p < 0.05) at 250 mg kg(-1) dose after 5 h post oral administration. Treatment of animals after 10 weeks of STZ-treatment with EEA (250 mg kg(-1)) for 21 days significantly reduced the elevated levels of blood glucose, % HbA1C, urea, uric acid and creatinine, and significantly increased the depressed serum insulin level. The extract exerted a significant inhibitory effect on alpha-glucosidase in a noncompetitive manner with an IC50 value of around 54 mu g mL(-1) and was found inhibitory to eye lens aldose reductase with an IC50 value of around 4.5 mu g mL(-1). The results suggest that EEA possesses antidiabetic effect associated with alpha-glucosidase and aldose reductase inhibition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available